Skip to Content

Retacrit

In the US, Retacrit (epoetin alfa systemic) is a member of the drug class recombinant human erythropoietins and is used to treat Anemia, Anemia Associated with Chronic Renal Failure, Anemia Prior to Surgery, Anemia - Chemotherapy Induced and Anemia - Drug Induced.

US matches:

UK matches:

Ingredient matches for Retacrit

Epoetin Zeta

Epoetin Zeta is reported as an ingredient of Retacrit in the following countries:

  • Austria
  • Belgium
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.



Hide